PFBT
FOLD

Parkside Financial Bank & Trust’s Amicus Therapeutics FOLD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.9K Hold
270
– – ﹤0.01% 1903
2025
Q4 		$3.85K Hold
270
– – ﹤0.01% 1888
2025
Q3 		$2.13K Buy
270
+180
+200% +$1.28K ﹤0.01% 1998
2025
Q2 		$534 Sell
90
-20
-18% -$129 ﹤0.01% 2511
2025
Q1 		$897 Buy
+110
New +$1.02K ﹤0.01% 2145

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Parkside Financial Bank & Trust's FOLD Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 270 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Parkside Financial Bank & Trust first reported a position in FOLD in Q1 2025 and has held it in 5 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Parkside Financial Bank & Trust held 270 shares of Amicus Therapeutics worth $3.9K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1903 holding.
  • Parkside Financial Bank & Trust first reported a position in Amicus Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.